We also did not consider how IL‐6R and IL‐6 trans‐signalling might contribute to cachexia development in our model, which would be an important future consideration as the liver is a source of IL‐6R and trans‐signalling is thought to mediate the pro‐inflammatory effects of IL‐6.10 The gene discussed is IL6; the disease is Cachexia.